Nebulised antibiotics for adults with cystic fibrosis

Thorax

Volumn 52, Issue SUPPL. 2, 1997, Pages

  Webb, A K ^a   Dodd, M E ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBENICILLIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM CONTAMINATION; BRONCHOSPASM; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG DISTRIBUTION; GRAM NEGATIVE INFECTION; HUMAN; INFECTION PREVENTION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL NEBULIZER; NEBULIZATION; OCCUPATIONAL EXPOSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RASH; REVIEW;

EID: 0030965380     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2008.s69     Document Type: Review

References (24)

1. Wilmott RW, Tyson SL, Mathews DJ. Cystic fibrosis survival rate: the influence of allergy and Pseudomonas aeruginosa. Am J Dis Child 1985;139:669-71.
2. Taylor R, Hodson M. Cystic fibrosis: antibiotic prescribing practices in the United Kingdom and Eire. Respir Med 1993;7:535-40.
3. Littlewood J, Miller MG, Ghoneim AT, Ramsden CH. Nebulised colomycin for early colonisation in cystic fibrois. Lancet 1985;i:865.
4. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991;338:725-6.
5. Hodson ME, Penketh ARL, Batten JC. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet 1981;ii: 1137-9.
6. Stead RJ, Hodson ME, Batten JC. Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients infected with Pseudomonas aeruginosa. Br J Dis Chest 1987;81:272-8.
7. Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, et al. Efficacy of aerosolised tobramycin in patients with cystic fibrosis. N Engl J Med 1993; 328:1740-6.
8. Steinkamp G, Tummler B, Gappa M, Albus A, Potel J, Goring G, et al. Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol 1989;6:9-18.
9. Mukhopadhyay S, Singh M, Cater JI, Ogston S, Franklin M, Olver RE. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Thorax 1996;51:364-8.
10. Stephens D, Garey N, Isles A, Levison H, Gold R. Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis. Pediatr Infect Dis 1983;2:209-11.
11. Maddison J, Dodd M, Webb AK. Nebulised colistin causes chest tightness in adults with cystic fibrosis. Respir Med 1994;88:145-7.
12. Chua HL, Collis GG, Le Souef PN. Bronchial response to nebulised antibiotics in children with cystic fibrosis. Eur Respir J 1990;3:114-6.
13. Littlewood JM, Smye SW, Cunliffe H. Aerosol antibiotic treatment in cystic fibrosis. Arch Dis Child 1993;68:788-92
14. Dodd ME, Maddison J, Abbott J, Webb AK. The effect of the tonicity of nebulised colistin on chest tightness and lung function in adults with cystic fibrosis. Eur Respir J 1993;6:515S.
15. Everard ML, Hardy JG, Milner AD. Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation. Thorax 1993;48:1045-6.
16. Newman SP, Woodman G, Clarke SW. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax 1988;43:318-22.
17. Le Conte P, Potel G, Peltier P, Horeau D, Caillon J, Juvin ME, et al. Lung distribution and pharamokinetics of aerosolised tobramycin. Am Rev Respir Dis 1993;147: 1279-82.
18. Smith AL, Ramsey BW, Hedges DL, Hack B, Williams-Warren J, Weber A, et al. Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis. Pediatr Pulmonol 1989;7:265-71.
19. Geers TJ, Cooke RE. The effect of sublethal levels of antibiotics on the pathogenicity of Pseudomonas aeruginosa from tracheal tissue. J Antimicrob Chem 1987;19:569-78.
20. McRorie T, Bosso J, Randolf L. Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high frequency audiometry. Am J Dis Child 1989;143:1328-32.
21. Barnes KL, Clifford R, Holgate ST, Murphy D, Comber P, Bell E. Bacterial contamination of home nebulisers. BMJ 1987;295:812.
22. Pitchford KC, Corey M, Highsmith AK, Periman R, Bannatyne R, Gold R, et al. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment. J Pediatr 1987,111:212-6.
23. Burdge DR, Nakiena EM, Noble MA. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993; 14:127-30.
24. Yamagishi Y, Fujita J, Takigawa K, Negayama K, Nakazawa T, Takahara J. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest 1993;103:1706-9.